SEPPIC launches SIMULGEL™ EG QD for Japanese market
SEPPIC launches SIMULGEL™ EG QD (1) , a thickening-stabilizing-texturizing polymer proved as Quasi-Drug (QD) additive in Japan.
SEPPIC has developed the QD analytical methods in order to prove the conformity of SIMULGEL ™ EG QD according to the QD monograph. A Certificate of Analysis conforming to the QD monograph is now provided with this product.
SIMULGEL™ EG QD is a liquid and multifunctional rheological modifier. It provides excellent thickening, stabilizing and texturizing properties. Compatible with most of ingredients used in topic formulation, it is suitable for products considered as Quasi-Drug categories in Japan, such as deodorants, whitening, anti-aging, oily skin or acne treatment etc.
Juanshu SHEN, product manager, stated: “SIMULGEL™ EG QD meets QD regulatory requirements in Japan and the local needs of our customers. This also shows our analytical expertise applied to polymers.”
(1) INCI name: Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer and Isohexadecane and Polysorbate 80;
QD additive name: Sodium Acrylate・Sodium Acryloyldimethyltaurate Copolymer / Isohexadecane / Polysorbate 80